Literature DB >> 31178345

Gastric Cancer - From Aetiology to Management: Differences Between the East and the West.

W L Chan1, K O Lam2, V H F Lee3, M Davidson4, T H So5, J S Li6, I Chau4, D L W Kwong3.   

Abstract

Gastric cancers are highly prevalent in both the East and the West, although they differ in aetiology and prognostic outcome. Management of gastric cancer from screening to definitive treatment varies substantially between Eastern and Western countries and regions, owing to numerous factors, including government incentives to carry out population-wide screening programmes to detect early disease, differences in clinical and biological tumour behaviours and responsiveness to treatment, patient accessibility to effective treatment, etc. This review highlights and contrasts the differences in tumour aetiology and histology, as well as the management approaches between the East and the West, which gives important insights and inspirations on future international multicentre research collaboration to combat this dreadful malignancy.
Copyright © 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aetiology; chemotherapy; gastric cancer; radiation therapy; surgery; targeted therapy

Mesh:

Year:  2019        PMID: 31178345     DOI: 10.1016/j.clon.2019.05.012

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  6 in total

Review 1.  Recent Developments of Systemic Chemotherapy for Gastric Cancer.

Authors:  Hiroyuki Arai; Takako Eguchi Nakajima
Journal:  Cancers (Basel)       Date:  2020-04-28       Impact factor: 6.639

2.  How are trial outcomes prioritised by stakeholders from different regions? Analysis of an international Delphi survey to develop a core outcome set in gastric cancer surgery.

Authors:  Bilal Alkhaffaf; Aleksandra Metryka; Jane M Blazeby; Anne-Marie Glenny; Paula R Williamson; Iain A Bruce
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.240

3.  Laparoscopic vs open total gastrectomy for advanced gastric cancer following neoadjuvant therapy: A propensity score matching analysis.

Authors:  Hai-Tao Hu; Fu-Hai Ma; Jian-Ping Xiong; Yang Li; Peng Jin; Hao Liu; Shuai Ma; Wen-Zhe Kang; Yan-Tao Tian
Journal:  World J Gastrointest Surg       Date:  2022-02-27

4.  Pleural and pulmonary dissemination patterns from gastric adenocarcinoma among patients with treated primary disease in Latin America.

Authors:  Juliana Restrepo; Carlos Andrés Carvajal-Fierro; Helena Facundo; Felipe González; Ana María Ramírez; Rafael Beltran; Ricardo Buitrago; Andrés-Felipe Jimenez; José Carreño; Ricardo Oliveros
Journal:  Front Surg       Date:  2022-09-07

Review 5.  Lymph Node Involvement in Advanced Gastric Cancer in the Era of Multimodal Treatment-Oncological and Surgical Perspective.

Authors:  Zuzanna Pelc; Magdalena Skórzewska; Karol Rawicz-Pruszyński; Wojciech P Polkowski
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

6.  Endoscopic Submucosal Dissection of Gastric Neoplastic Lesions: An Italian, Multicenter Study.

Authors:  Raffaele Manta; Giuseppe Galloro; Francesco Pugliese; Stefano Angeletti; Angelo Caruso; Francesco P Zito; Santi Mangiafico; Riccardo Marmo; Angelo Zullo; Gianluca Esposito; Bruno Annibale; Massimiliano Mutignani; Rita Conigliaro
Journal:  J Clin Med       Date:  2020-03-09       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.